Tuesday 20th June 2023 |
Text too small? |
Auckland, New Zealand, 20 June 2023 - Fisher & Paykel Healthcare Corporation Limited attaches a copy of its presentation for the ASX’s CEO Connect webinar to be held later today.
There is no new material information contained within the presentation.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Media & Investor Contacts:
Hayden Brown
Head of Capital Markets & Investor Relations
hayden.brown@fphcare.co.nz
+64 (0) 27 807 8073
Dan Adolph
Senior Communications & Investor Relations Manager
daniel.adolph@fphcare.co.nz
+64 (0) 22 511 4050
Authorised by Raelene Leonard, General Counsel and Company Secretary.
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report